What Can You Expect at Industry’s Dedicated Complement Forum in 2026?
The 10th Complement-Based Drug Development Summit returns as the industry's only dedicated forum uniting complement leaders to tackle the key challenges in complement biology and drug development.
Bringing together 80+ biotech innovators, pharma leaders, and academic KOLs, this industry-led meeting provides a focused opportunity to advance novel targets, refine modality strategy, navigate clinical development, and expand into new indications.
Across 3 days of discussion-led workshops, data-driven presentations, clinical insights, and expert panels, engage with the leaders behind renal readouts, next-generation targets, and emerging CNS and ophthalmology programs to benchmark your approach, strengthen differentiation, and build partnerships that de-risk complement drug development.
Unmissable Event Highlights
Expand the Range of Complement Targets
Explore novel cascade targets across the classical, alternative and lectin pathway, pushing beyond C3 and C5 to explore Factor B, Factor H, C1q and more, with insights from:
Apply Complement Strategies to a Plethora of Indications
With demonstrated clinical success in nephrology, a complement-based approach is now being applied to ophthalmology, oncology, haematology, neurodegeneration and more. Uncover data from:
Pioneer Novel Complement Modalities
From siRNA to small molecules, gene therapies to novel biologics, uncover the latest strategies behind durable, selective and tolerable complement modalities, with data from:
Push the Boundaries of Complement Innovation
Debate the future of complement therapeutics, exploring the role of intracellular complement, applying a complement-based approach to non-orphan disease, and strategizing future direction, with:
Attending Companies Include